Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
1.36%
operating margin TTM
8.25%
revenue TTM
1.92 Billion
revenue per share TTM
14.55$
valuation ratios | |
|---|---|
| pe ratio | 1,207.60 |
| peg ratio | 10.73 |
| price to book ratio | 224.93 |
| price to sales ratio | 16.47 |
| enterprise value multiple | 276.57 |
| price fair value | 224.93 |
profitability ratios | |
|---|---|
| gross profit margin | 83.99% |
| operating profit margin | 8.25% |
| pretax profit margin | -1.0% |
| net profit margin | 1.36% |
| return on assets | 0.9% |
| return on equity | 26.13% |
| return on capital employed | 8.03% |
liquidity ratios | |
|---|---|
| current ratio | 2.54 |
| quick ratio | 2.49 |
| cash ratio | 0.96 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 53.53 |
| operating cycle | 163.22 |
| days of payables outstanding | 83.50 |
| cash conversion cycle | 79.73 |
| receivables turnover | 3.33 |
| payables turnover | 4.37 |
| inventory turnover | 6.82 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.57 |
| debt equity ratio | 11.86 |
| long term debt to capitalization | 0.91 |
| total debt to capitalization | 0.92 |
| interest coverage | 1.63 |
| cash flow to debt ratio | 0.10 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.68 |
| cash per share | 20.73 |
| operating cash flow per share | 2.02 |
| free cash flow operating cash flow ratio | 0.83 |
| cash flow coverage ratios | 0.10 |
| short term coverage ratios | 1.66 |
| capital expenditure coverage ratio | 5.97 |
Frequently Asked Questions
When was the last time Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) reported earnings?
Alnylam Pharmaceuticals, Inc. (ALNY) published its most recent earnings results on 03-10-2025.
What is Alnylam Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)'s trailing twelve months ROE is 26.13%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Alnylam Pharmaceuticals, Inc. (ALNY) currently has a ROA of 0.9%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ALNY's net profit margin stand at?
ALNY reported a profit margin of 1.36% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ALNY's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.54 in the most recent quarter. The quick ratio stood at 2.49, with a Debt/Eq ratio of 11.86.